Title
Category
Credits
Event date
Cost
Rapid Clinical Updates: Advanced Therapy for End-Stage Heart Failure
  • Free-to-Member
  • Rapid Clinical Updates
  • 1.00 ABIM MOC Self Evaluation Points
  • 1.00 CME - AMA PRA Category 1 Credit™
  • 1.00 Non-physician
$95.00
This session is presented by Megan Kamath, MD and Ebrahim Barkoudah, MD, FACP, MPH, SFHM. Our moderator is Lily Ackermann, ScM, MD, FACS, SFHM. This session explores cutting-edge interventions for end-stage heart failure patients, including mechanical circulatory support devices, cardiac transplantation evaluation criteria, and palliative care integration. We'll discuss patient selection for advanced therapies, review post-intervention management protocols, and examine recent outcome data. Case-based scenarios will illustrate decision-making pathways and multidisciplinary team approaches to optimize patient outcomes in this complex population.
Climate Change and Cancer
  • Climate Health
  • Free-to-Member
  • 0.50 ABIM MOC Self Evaluation Points
  • 0.50 CME - AMA PRA Category 1 Credit™
  • 0.50 Non-physician
$55.00
SummaryAir pollution is a often unrecognized risk factor for developing and dying from lung cancer, but is labelled a Class I carcinogen by the International Agency for Research on Cancer (IARC).This module will review the mechanism of action by which air pollution and it constituents, particularly PM2.5, cause lung cancer and its effect on lung cancer patients worldwide.
Rapid Clinical Updates: Cardio-Renal-Metabolic Disease and Care Models for Hospital Medicine
  • Free-to-Member
  • Rapid Clinical Updates
  • 1.00 ABIM MOC Self Evaluation Points
  • 1.00 CME - AMA PRA Category 1 Credit™
  • 1.00 Non-physician
$95.00
This session is presented by Muthiah Vaduganathan, MD, MPH. Our moderators are Lily Ackermann ScM, MD, FACS, SFHM and Ebrahim Barkoudah, MD, FACP, MPH, SFHM. Join us for a special session on Cardio-Renal-Metabolic Disease and Care Models for Hospital Medicine. We are honored to have an internationally renowned expert to present the latest practice changing research that significantly impacts patient care. We will review the latest clinical trials and how they impact patient care and guideline-recommended use of nonsteroidal mineralocorticoid receptor antagonists (nsMRAs) for managing cardio-kidney-metabolic (CKM) conditions. There will be a review of the latest on the novel use of nsMRAs in patients with type 2 diabetes, cardiovascular disease, and CKD. We will discuss implications for inpatients and starting GDMT including the latest on the new nsMRAs in managing patients with heart failure, type 2 diabetes, and CKD.
Recognizing Porphyria Attacks: When Severe Abdominal Pain Can Last up to 7 Days
  • Free-to-Member
$0.00
This is an EXCEL Continuing Education continuing medical education activity supported by an educational grant from Recordati Rare Disease.TARGET AUDIENCEThis activity is intended for hospitalists, emergency room physicians, pediatricians, hematologists, geneticists, genetic counselors, dermatologists, internal medicine and primary care physicians, registered nurses and nurse practitioners, and physician assistants.

Pages